VEC.L Share News (VEC)

VEC.L Information

There is currently no data for VEC

Vectura, Skyepharma Merger Cleared By UK Competition Authority

Mon, 16th May 2016 16:13

LONDON (Alliance News) - Vectura Group PLC and Skyepharma PLC on Monday said that the UK's Competition & Markets Authority confirmed their proposed merger does not qualify for investigation under investigation under the Enterprise Act 2002.

Vectura and Skyepharma, which are both focused on treatments for asthma and other respiratory illnesses, agreed to an all-share merger in March.

Shares in Vectura closed up 0.9% at 169.4 pence. Shares in Skyepharma closed up 1.0% at 467.90p.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

More News

26 Nov 2018 09:05

Vectura Discontinues VR375 As Phase Three Study Misses Endpoints

LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a

22 Oct 2018 08:59

Vectura Says New Chief Financial Officer Fry Has Started Week Early

LONDON (Alliance News) - Medical devices developer Vectura Group PLC said Monday Paul Fry will become chief financial officer immediately, rather than from Monday next week.Fry succeeds who

11 Sep 2018 09:40

Vectura Interim Loss Narrows On Higher Revenue And Lower Expenses

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC on Tuesday said its loss narrowed in the first half of 2018 as it reduced operating costs.Pretax loss narrowed to GBP29.9 in a

11 Sep 2018 08:18

Vectura's solid interims turn focus further forward

(Sharecast News) - Vectura kept guidance for the full year unchanged as the inhaled medicines specialist reported robust revenue and said it has identified pipeline projects with potential annual sales of over $250m.

10 Sep 2018 12:49

Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.The company said it expects further launches across to a

4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 September Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

23 Aug 2018 14:17

Thursday broker round-up

(Sharecast News) - TalkTalk: Barclays upgrades to overweight with a target price of 150p.

21 Aug 2018 12:31

Vectura concludes two paediatric studies into VR647

(Sharecast News) - Vectura announced the successful conclusion of two paediatric studies to support the potential use of VR647, its wholly-owned drug/device combination asset, on Tuesday.

21 Aug 2018 09:45

Vectura Group Gets Positive Results From VR647 Phase II Study

LONDON (Alliance News) - Vectura Group PLC said Tuesday that it received positive results form two paediatric studies of its VR647 inhalation system to manage asthma.The two studies, a and

17 May 2018 10:55

Vectura Group On Track To Achieve Expected Full-Year Revenue

LONDON (Alliance News) - Inhaled product design and development firm Vectura Group PLC said on Thursday based on its trading performance for the year-to-date revenue is currently in line with is a

11 May 2018 11:35

Nuformix Appoints Former Ventura Chief Executive To Board

LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a

10 May 2018 16:16

UK Shareholder Meetings Calendar - Next 7 Days

Friday 11 MayBBA AviationMan GroupRSA Insurance GroupJohn Wood Advanced 14 15 Pacific

24 Apr 2018 13:16

Sosei Group Confirms It Will Not Make Takeover Offer For Vectura

LONDON (Alliance News) - Japanese biotechnology firm Sosei Group Corp said on Tuesday, noting unspecified press reports, it does not intend to make an offer for Vectura Group PLC.Shares in

23 Apr 2018 09:55

Vectura Adds Ex-GSK And Sanofi Executive Whitaker To Board From June

LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of

20 Apr 2018 09:59

Vectura CFO Andrew Derodra Leaves To Take Up Role At Unilabs

LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the a

Latest Share Chat

VEC.L Share News (VEC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vectura, Skyepharma Merger Cleared By UK Competition Authority

Login to your account

Quickpicks are a member only feature

Login to your account